About DiaSorin
DiaSorin is a company based in Saluggia (Italy) founded in 1968. The company has 30 employees as of March 28, 2024. DiaSorin has completed 2 acquisitions, including Focus DX and Luminex Corporation. DiaSorin offers products and services including LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B.
- Headquarter Saluggia, Italy
- Employees 30 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Diasorin Healthcare India Private Limited
- Date of Incorporation 10 Jul, 2012
- Jurisdiction Mumbai, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DiaSorin
DiaSorin offers a comprehensive portfolio of products and services, including LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B.
Instrument for immunodiagnostic testing of infectious diseases
System for detecting pathogens in biological samples
Platform for bead-based multiplexing in diagnostics
Kit for identifying respiratory viruses quickly
People of DiaSorin
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Sales and Marketing
18 people
Software Development Team
11 people
Finance and Accounting
10 people
Human Resources and Administration
8 people
Corporate Team
4 people
Senior Team
4 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of DiaSorin
Investors in DiaSorin
DiaSorin has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Public Health Emergency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for DiaSorin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DiaSorin
DiaSorin has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Focus DX and Luminex Corporation.
Investment portfolio details for DiaSorin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of instruments, reagents and kits for clinical diagnostics and life science research
|
Locked | Locked | 1995 | Locked | |
|
Diagnostic assays and reagents for infectious diseases are developed.
|
Locked | Locked | 1978 | Locked |
Complete acquisition details for DiaSorin
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - DiaSorin
Detailed financials for DiaSorin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diasorin Comparisons
Peer comparison for DiaSorin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DiaSorin
Detailed competitors of DiaSorin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diasorin
Complete news archive for DiaSorin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DiaSorin
DiaSorin was founded in 1968 and raised its 1st funding round 41 years after it was founded.
DiaSorin is headquartered in Saluggia, Italy. It is registered at Saluggia, Piemonte, Italy.
As of Mar 28, 2024, the latest employee count at DiaSorin is 30.
Annual revenue of DiaSorin is $1.24B as on Dec 31, 2024.
DiaSorin was founded in 1968 in Saluggia, Italy. Reagent kits for in vitro diagnostics are developed and commercialized, with emphasis on immunodiagnostics and molecular diagnostics sectors. These kits are applied in hospital and private testing laboratories for infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology, and endocrinology. Offices are operated in Europe, the United States, Central and South America, Asia, and South Africa as of January 2016.
DiaSorin offers LIAISON XL, VERIGENE System, MAGPIX System, and Simplexa COVID-19 & Flu A/B.
DiaSorin has made 2 acquisitions, including Focus DX, and Luminex Corporation.
DiaSorin has 2 investors. Key investors include HHS, and Public Health Emergency.